Financhill
Buy
52

ONC Quote, Financials, Valuation and Earnings

Last price:
$253.77
Seasonality move :
15.69%
Day range:
$249.52 - $258.50
52-week range:
$141.31 - $287.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.79x
P/B ratio:
8.18x
Volume:
326.7K
Avg. volume:
370.1K
1-year change:
62.64%
Market cap:
$28.6B
Revenue:
$3.8B
EPS (TTM):
-$3.77

Earnings Data

Next earnings date for ONC
Aug 07
2025
Most recent earnings per share
--
Beat by $0.74
(May 7/2025)
Consensus Estimate
-$0.74
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ONC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $1.2B -- -- $0.20 --
05/07/2025 Q1 $1.1B $1.1B -- -$0.74 --
02/27/2025 Q4 $1B $1.1B -$1.43 -$1.02 -$0.41
11/12/2024 Q3 $984.2M $1B -$1.17 -$1.11 -$0.06
06/30/2024 Q2 $809.2M $929.2M -$1.17 -$2.14 $0.97
03/31/2024 Q1 $675.2M $751.7M -$2.47 -$2.54 $0.07
12/31/2023 Q4 $638.3M $634.4M -$3.51 -$3.45 -$0.06
09/30/2023 Q3 $578.2M $781.3M $1.95 -$2.93 $4.88
06/30/2023 Q2 $515.4M $595.3M -$3.64 -$2.98 -$0.66
03/31/2023 Q1 $449.4M $447.8M -$3.38 -$3.66 $0.28
12/31/2022 Q4 -- $380.1M -$4.29 -- --
09/30/2022 Q3 -- $387.6M -$5.33 -- --
06/30/2022 Q2 -- $341.6M -$5.46 -- --
03/31/2022 Q1 -- $306.6M -$4.29 -- --
12/31/2021 Q4 -- $214M -$6.11 -- --
09/30/2021 Q3 -- $206.4M -$4.72 -- --
06/30/2021 Q2 -- $150M -$5.23 -- --
03/31/2021 Q1 -- $605.9M $0.65 -- --
12/31/2020 Q4 -- $100.1M -$5.20 -- --
09/30/2020 Q3 -- $91.1M -$4.81 -- --
06/30/2020 Q2 -- $65.6M -$4.29 -- --
03/31/2020 Q1 -- $52.1M -$4.70 -- --
12/31/2019 Q4 -- $56.9M -$6.37 -- --
09/30/2019 Q3 -- $50.1M -$5.07 -- --
06/30/2019 Q2 -- $243.3M -$1.43 -- --
03/31/2019 Q1 -- $77.8M -$2.86 -- --
12/31/2018 Q4 -- $58.7M -$4.55 -- --
09/30/2018 Q3 -- $54.2M -$2.47 -- --
06/30/2018 Q2 -- $52.8M -$2.86 -- --
03/31/2018 Q1 -- $32.5M -$2.08 -- --
12/31/2017 Q4 -- $18.2M -$2.18 -- --
09/30/2017 Q3 -- $220.2M $2.60 -- --
06/30/2017 Q2 -- -- -$1.56 -- --
03/31/2017 Q1 -- -- -$1.30 -- --
12/31/2016 Q4 -- -- -$0.95 -- --
09/30/2016 Q3 -- -- -$1.04 -- --
06/30/2016 Q2 -- $393K -$0.78 -- --
03/31/2016 Q1 -- $677K -$0.91 -- --
12/31/2015 Q4 -- $4.7M -$0.86 -- --
09/30/2015 Q3 -- $1.4M -$0.26 -- --
06/30/2015 Q2 -- $1.4M -$0.10 -- --

BeOne Medicines Earnings Questions

  • How Much did BeOne Medicines Generate in Revenue Last Quarter?

    BeOne Medicines reported $1.1B worth of top line sales in its most recent quarter.

  • Did BeOne Medicines Beat Earnings Last Quarter?

    BeOne Medicines announced earnings per share of -- which represents a beat of analyst forecast a -$0.74 per share.

  • Is BeOne Medicines Profitable?

    BeOne Medicines reported $952.3M that represents $8.57 per share over the last quarter.

  • What is the Analyst Consensus for BeOne Medicines EPS Next Year?

    BeOne Medicines's earnings are forecast to decrease from -$6.11 per share to -$5.69 per share next year representing a decrease of -98.91%.

  • When is BeOne Medicines's Earnings Date?

    BeOne Medicines's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.

Buy
79
ARQQ alert for Jun 18

Arqit Quantum [ARQQ] is up 6.36% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 3.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock